Coronavirus (COVID-19) updates for UC San Diego Health patients and visitors. Learn More

Menu
Search

UC San Diego Hosts Kyoto Prize Laureate Honored cancer researcher to present free public lecture March 3

 

September 22, 2005  |  

Kyoto Prize Laureate Alfred G. Knudson Jr., MD, PhD, of the Fox Chase Cancer Center in Philadelphia, will discuss his groundbreaking work at a free lecture beginning at 4:30 p.m. March 3 in UC San Diego’s Price Center Theater.

A geneticist and physician, Knudson is internationally recognized for his "two-hit" theory of cancer causation, which explained the relationship between the hereditary and non-hereditary forms of a cancer and predicted the existence of tumor-suppressor genes that can suppress cancer cell growth. This now-confirmed theory has advanced understanding of errors in the genetic program that turn normal cells into cancer cells.

As one of three 2004 Kyoto Prize Laureates, Knudson’s appearance is sponsored by the Inamori Foundation of Japan, established in 1984 to honor and support individuals who have contributed greatly to scientific progress, cultural advance and human betterment.

He will be introduced by Ernest Beutler, MD, chairman of the Department of Molecular and Experimental Medicine at The Scripps Research Institute.

Other Kyoto Prize Laureates appearing in San Diego during the three-day Kyoto Laureate Symposium are computer scientist Alan Curtis Kay, PhD, who will speak at 9:30 a.m. March 3 at San Diego State University, and philosopher Jurgen Habermas, who will speak at 3 p.m. March 4 at the University of San Diego.

For further information contact Betsy Shed at 858-822-2611 or Kyoto@ucsd.edu.

#  #  #

News Media Contact: Nancy Stringer, 619-543-6163




Media Contact

Share This Article


Related News

9/23/2020
Analyzing anonymized patient medical records, UC San Diego researchers discovered that cholesterol-lowering statins reduced risk of severe COVID-19 infection, while lab experiments uncovered a cellula ...
9/21/2020
Moores Cancer Center at UC San Diego Health is using advanced imaging, genomics, personalized medicine and new therapies to treat patients like Brian McCloskey, who has stage IV prostate cancer.
9/17/2020
A consortium of 12 health systems, led by UC San Diego Health, introduces COVID19questions.org, a site where clinicians, researchers, patients and the general public are invited to submit questions th ...
9/16/2020
Early detection and intervention stanched the first known introductions of the SARS-CoV-2 virus into North America and Europe, validating the effectiveness of quick, comprehensive testing and contact ...



Follow Us